Simultaneous quantitative determination of metoprolol, atorvastatin and ramipril in capsules by a validated stability-indicating RP-UPLC method

Scientia Pharmaceutica

Volumn 78, Issue 4, 2010, Pages 821-834

  Seshadri, Raja Kumar ^a   Desai, Makarand Madhukar ^a   Raghavaraju, Thummala Veera ^a   Krishnan, Deepa ^a   Rao, Dama Venugopala ^a   Chakravarthy, Ivon Elisha ^b  

^a DR REDDY'S LABORATORIES LTD   (India)

^b RAYALASEEMA UNIVERSITY   (India)

Author keywords

Chromatography; Fixed dose combination; Impurities; Method validation; Reviro

Indexed keywords

ATORVASTATIN; METOPROLOL SUCCINATE; PLACEBO; RAMIPRIL;

ARTICLE; DRUG CAPSULE; DRUG IMPURITY; DRUG STABILITY; DRUG STRUCTURE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 78650219501     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1004-14     Document Type: Article

References (34)

1. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000; 342(3): 145-153. doi:10.1056/NEJM200001203420301
2. Arnold JM, Yusuf S, Young J, Mathew J, Johnstone D, Avezum A, Lonn E, Pogue J, Bosch J. Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation. 2003; 107: 1284-1290. doi:10.1161/01.CIR.0000054165.93055.42
3. Dagenais GR, Yusuf S, Bourassa MG, Yi Q, Bosch J, Lonn EM, Kouz S, Grover J; HOPE Investigators. Effects of Ramipril on Coronary Events in High-Risk Persons: Results of the Heart Outcomes Prevention Evaluation Study. Circulation. 2001; 104: 522-526. doi:10.1161/hc3001.093502
4. Budavari, S, Eds, In. An Encyclopedia of Chemicals, Drugs and Biologicals. The Merck Index; 12 th Edn., Merck & Co., Inc., Whitehouse Station, NJ. 1996; 146.
5. Reynolds JEF. Martindale: The Extra Pharmacopoeia; 31st Edn., Royal Pharmaceutical Society, London. 1996; 1302.
6. Reich JW. In: Gennaro AR, Ed., Remington. The Science and Practice of Pharmacy, Vol-II. 20 th Edn, Mack Publishing Company, Easton, PA. 2000; 1294.
7. The Merck Index (14th Ed.). 2006; 493 & 6149.
8. Thamake SL, Jadhav SD, Pishawikar SA. Development and validation of method for simultaneous estimation of Atorvastatin Calcium and Ramipril from capsule dosage form by first order derivative spectroscopy. Asian J Res Chem. 2009; 2: 52-53.
9. Yogesh BZ, Santosh RK, Simpi CC. Simultaneous Estimation of Atorvastatin and Ramipril by First Derivative Spectrophotometric method. J Pharm Res. 2009; 2: 874-877.
10. Bharat GC, Ashok BP. Simultaneous Spectrophotometric Estimation of Atorvastatin Calcium and Amlodipine Besylate in tablet dosage forms. Int J ChemTechRes. 2010; 2: 633 639.
11. Brijesh S, Patel DK, Ghosh SK. Development of Reverse-Phase HPLC Method for Simultaneous Analysis of Metoprolol Succinate and Hydrochlorothiazide in a Tablet Formulation. Trop J Pharm Res. 2009; 8: 539-543.
12. Phale MD, Hamrapurkar PD. A Validated and Simplified RP-HPLC of Metoprolol Succinate from Bulk Drugs. Asian J Res Chem. 2009; 2: 119-122.
13. Sohan SC, Mohammed Imran, Dinesh MS. RP-HPLC method for simultaneous estimation of Amlodipine and Metoprolol in tablet formulation. Asian J Pharm. 2008; 2: 232-234.
14. LI Qin, Wang R. Simultaneous analysis of Tramadol, Metoprolol and their metabolites in human plasma and urine by high performance liquid chromatography. Chin Med J. 2006; 119: 2013-2021. PMid:17199947
15. Dongre VG, Shah SB, Karmuse PP, Phadke M, Jadhav VK. Simultaneous determination of Metoprolol succinate and Amlodipine besylate in pharmaceutical dosage form by HPLC. J Pharm Biomed Anal. 2008; 46: 583-586. doi:10.1016/j.jpba.2007.11.006
16. Baranowska I, Wilczek A. Simultaneous RP-HPLC Determination of Sotalol, Metoprolol, α-Hydroxymetoprolol, Paracetamol and Its Glucuronide and Sulfate Metabolites in Human Urine. Anal Sci. 2009; 25: 769-772. doi:10.4103/0250-474X.25738
17. Shah DA, Bhatt KK, Mehta RS, Shankar MB, Baldania SL. RP-HPLC method for the determination of Atorvastatin calcium and Nicotinic acid in combined tablet dosage form. Indian J Pharm Sci. 2007; 69: 700-703. doi:10.4103/0250-474X.25738
18. Rajeswari KR, Sankar GG, Rao AL, Seshagirirao JVLN. RP-HPLC method for the simultaneous determination of Atorvastatin and Amlodipine in tablet dosage form. Indian J Pharm Sci. 2006; 68: 275-277. doi:10.4103/0250-474X.25738
19. Lucie N, Dalibor S, Petr S. HPLC methods for the determination of Simvastatin and Atorvastatin. Trends Anal Chem. 2008; 27: 352-367. doi:10.1016/j.trac.2008.01.013
20. Zahid Z, Farooqui MN, Mangle AA, Nikalje AG. Stability-indicating high performance liquid chromatographic determination of Atorvastatin calcium in pharmaceutical dosage form. Afr J Pharm Pharmacol. 2008; 2: 204-210.
21. Belal F, Al-Zaagi IA, Gadkariem EA, Abounassif MA. A stability-indicating LC method for the simultaneous determination of Ramipril and Hydrochlorothiazide in dosage forms. J Pharm Biomed Anal. 2001; 24: 335-342. doi:10.1016/S0731-7085(00)00474-X
22. Kurade VP, Pai MG, Gude R. RP-HPLC estimation of Ramipril and Telmisartan in tablets. Indian J Pharm Sci. 2009; 71: 148-151. doi:10.4103/0250-474X.54283
23. Lincy J, Mathew G, Venkata RRB. Simultaneous estimation of Atorvastatin and Ramipril by RP-HPLC and Spectroscopy. Pak J Pharm Sci. 2008; 21: 282-284. PMid:18614425
24. Hiral JP, Bhanubhai NS, Natvarlal JP, Ishwarsinh SR, Bhavesh HP. Simultaneous Estimation of Atorvastatin Calcium, Ramipril and Aspirin in Capsule Dosage Form by RP-LC. Chromatographia. 2009; 69: 91-95. doi:10.1365/s10337-008-0831-z
25. Panchal HJ, Suhagia BN, Patel NJ, Patel SSK. Simultaneous HPTLC analysis of Atorvastatin calcium, Ramipril, and Aspirin in a capsule dosage form. J Planar Chromatogr Mod TLC. 2009; 22: 265-271. doi:10.1556/JPC.22.2009.4.5
26. Sarkar AK, Ghosh D, Das A, Selvan PS, Gowda KV, Mandal U, Bose A, Agarwal S, Bhaumik U, Pal TK. Simultaneous determination of Metoprolol succinate and Amlodipine besylate in human plasma by liquid chromatography-tandem mass spectrometry method and its application in bioequivalence study. J Chromatogr B. 2008; 873: 77-85. doi:10.1016/j.jchromb.2008.07.040
27. Kadav AA, Vora DN. Stability-indicating UPLC method for simultaneous determination of Atorvastatin, Fenofibrate and their degradation products in tablets. J Pharm Biomed Anal. 2008; 48: 120-126. doi:10.1016/j.jpba.2008.05.018
28. Novakova L, Vickova H, Satinsky D, Sadilek P, Solichova D, Blaha M, Blaha V, Solich P. Ultra high performance liquid chromatography tandem mass spectrometric detection in clinical analysis of Simvastatin and Atorvastatin. J Chromatogr B. 2009; 877: 2093-2103. doi:10.1016/j.jchromb.2009.05.052
29. Attia MS. Spectrofluorimetric assessment of Ramipril using optical sensor Samarium ion doxycycline complex doped in sol-gel matrix. J Pharm Biomed Anal. 2010; 51: 7-11. doi:10.1016/j.jpba.2009.08.017
30. Zhang Y, Wu HL, Xia AL, Zhu SH, Han QJ, Yu RQ. Fluorescence determination of Metoprolol in human plasma by trilinear decomposition-based calibration techniques. Anal Bioanal Chem. 2006; 386: 1741-1748. doi:10.1007/s00216-006-0732-7
31. Murray GJ, Danaceau JP. Simultaneous extraction and screening of diuretics, beta-blockers, selected stimulants and steroids in human urine by HPLC-MS/MS and UPLC-MS/MS. J Chromatogr B. 2009; 877: 3857-3864. doi:10.1016/j.jchromb.2009.09.036
32. British Pharmacopoeia, Medicinal and Pharmaceutical Substances 2009; I and II: 3933-3937.
33. British Pharmacopoeia, Medicinal and Pharmaceutical Substances 2009; I and II: 5160-5167.
34. ICH - Q2 (R1) (2005). Guideline on Validation of Analytical Procedure. Text and Methodology.